Cargando…
NF-κB in Hematological Malignancies
NF-κB (Nuclear Factor Κ-light-chain-enhancer of activated B cells) transcription factors are critical regulators of immunity, stress response, apoptosis, and differentiation. Molecular defects promoting the constitutive activation of canonical and non-canonical NF-κB signaling pathways contribute to...
Autores principales: | Imbert, Véronique, Peyron, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489813/ https://www.ncbi.nlm.nih.gov/pubmed/28561798 http://dx.doi.org/10.3390/biomedicines5020027 |
Ejemplares similares
-
Pharmacological targeting of NF-κB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells
por: Lagadec, P, et al.
Publicado: (2008) -
Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies
por: Kennedy, Ruth, et al.
Publicado: (2018) -
Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies
por: Mancini, Stéphane J.C., et al.
Publicado: (2021) -
NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy
por: Grondona, Paula, et al.
Publicado: (2018) -
Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions
por: Baud, Véronique, et al.
Publicado: (2016)